Akathisia in adults with severe and profound intellectual disability: A psychometric study of the MEDS and ARMS

Journal of Intellectual and Developmental Disability

Volumn 33, Issue 2, 2008, Pages 171-176

  Garcia, Mark J ^a   Matson, Johnny L ^b  

^a Pinecrest Developmental Center   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Adults; Adverse drug reaction; Akathisia; ARMS; Drug side effects; Intellectual disability; MEDS

Indexed keywords

ARIPIPRAZOLE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADULT; AGED; AKATHISIA; AKATHISIA RATINGS OF MOVEMENT SCALE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DRUG USE; FEMALE; HUMAN; INTELLECTUAL IMPAIRMENT; MAJOR CLINICAL STUDY; MALE; MATSON EVALUATION OF DRUG SIDE EFFECTS; PSYCHOMETRY; RATING SCALE; SYMPTOM;

ADULT; AGED; AKATHISIA, DRUG-INDUCED; ANTIPSYCHOTIC AGENTS; CASE-CONTROL STUDIES; DRUG MONITORING; FEMALE; HUMANS; LOUISIANA; MALE; MENTAL RETARDATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROLOGIC EXAMINATION; OBSERVER VARIATION; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; STATISTICS, NONPARAMETRIC;

EID: 45849133412     PISSN: 13668250     EISSN: 14699532     Source Type: Journal    
DOI: 10.1080/13668250802065190     Document Type: Article

References (27)

1. Advokat, C. D., Mayville, E. A., & Matson, J. L. (2000). Side effect profiles of atypical antipsychotics, typical antipsychotics, or no psychotropic medications in persons with mental retardation. Research in Developmental Disabilities, 21(1), 75-84.
2. Aman, M. G., Singh, N. N., & Stewart, A. W. (1985). Psychometric characteristics of the Aberrant Behavior Checklist. American Journal of Mental Deficiency, 89(5), 492-502.
3. Bodfish, J. W., Newell, K. M., Sprague, R. L., Harper, V. N., & Lewis, M. H. (1997). Akathisia in adults with intellectual disability: Development of the Akathisia Ratings of Movement Scale. American Journal on Mental Retardation, 101(4), 413-423.
4. Borthwick-Duffy, S. A., & Eyman, R. K. (1990). Who are the dually diagnosed? Psychopathology in the mentally retarded. Journal on Mental Retardation, 94, 586-595.
5. Brune, M., & Braunig, P. (1997). Akathisia. Fortschritte Der Neurologie Psychiatrie, 65(9), 396-406.
6. Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Erlbaum.
7. Cooper, S. A. (1997). Psychiatry of elderly compared to younger adults with intellectual disabilities. Journal of Applied Research in Intellectual Disabilities, 10(4), 303-311.
8. Erdfelder, E., Faul, F., & Buchner, A. (1996). GPOWER: A general power analysis program. Behavior Research Methods, Instruments, & Computers, 28, 1-11.
9. Ferrando, S. J., & Eisendrath, S. J. (1991). Adverse neuropsychiatric effects of dopamine antagonist medications: Misdiagnosis in the medical setting. Psychosomatics: Journal of Consultation Liaison Psychiatry, 32(4), 426-432.
10. Garcia, M. (2006). Psychometric validity for the Matson Evaluation of Drug Side-effects and the Akathisia Rating of Movement Scale, Unpublished doctoral dissertation, Louisiana State University, LA.
11. Gerlach, J., Korsgaard, S., Clemmesen, P., Lund Lauersen, A. M., Magelund, G., & Noring, U., et al. (1993). The St. Hans Rating Scale for extrapyramidal syndromes: Reliability and validity. Acta Psychiatrica Scandinavica, 87(4), 244-252.
12. Gualtieri, C. T. (1993). The problem of tardive akathisia. Brain& Cognition, 23(1), 102-109.
13. Hirose, S. (2001). Restlessness in suboccipital muscles as a manifestation of akathisia. Psychiatry and Clinical Neurosciences, 55(1), 81-82.
14. Marsalek, M. (1997). Mental aspects of drug-induced extrapyramidal disorders. Homeostasis in Health & Disease, 38(4), 176-177.
15. Matson, J. L., & Baglio, C. S. (1998). Administrator's Manual: Matson Evaluation of Drug Side Effects (MEDS). Baton Rouge, LA: Disability Consultants, LLC.
16. Matson, J. L., Mayville, E. A., Bielecki, J., Barnes, W. H., Bamburg, J. W., & Baglio, C. S. (1998). Reliability of the Matson Evaluation of Drug Side Effects Scale (MEDS). Research in Developmental Disabilities, 19(6), 501-506.
17. McGillivray, J. A., & McCabe, M. P. (2004). Pharmacological management of challenging behavior of individuals with intellectual disability. Research in Developmental Disabilities, 25, 523-537.
18. Nelson, D. E. (2001). Akathisia - A brief review. Scottish Medical Journal, 46, 133-134.
19. Patel, P., Goldberg, D., & Moss, S. (1993). Psychiatric morbidity in older people with moderate and severe learning disability. II. The prevalence study. British Journal of Psychiatry, 163, 481-491.
20. Sachdev, P. S. (1994). Research diagnostic criteria for drug-induced akathisia: Conceptualization, rationale and proposal. Psychopharmacology, 114, 181-186.
21. Sachdev, P. S. (1995). Akathisia and restless legs. New York: Cambridge University Press.
22. Sachdev, P. S., & Kruk, J. (1994). Clinical characteristics and predisposing factors in acute drug induced akathisia. Archives of General Psychiatry, 51, 963-974.
23. Siegel, S., & Castellan, N. J. (1988). Nonparametric statistics for the behavioral sciences (2nd ed.). New York: McGraw-Hill.
24. Simpson, G. M., & Angus, J. W. S. (1970). A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica, 45(S212), 11-19.
25. Stahl, S. M. (1985). Akathisia and tardive dyskinesia: Changing concepts. Archives of General Psychiatry, 42(9), 915-917.
26. Stubbs, J. H., & Halstead, S. M. (2000). Pseudoakathisia: A review and two case reports. Comprehensive Psychiatry, 41(1), 70-72.
27. Wojcik, J. D., Gelenberg, A. J., LaBrie, R. A., & Mieske, M. (1980). Prevalence of tardive dyskinesia in an outpatient population. Comprehensive Psychiatry, 21, 370-379.